- US12491361utility2025Tolerable and Minimally Invasive Skin Electroporation Device0 cites
- US12492243utility2025DNA Antibody Constructs for Use Against Pseudomonas Aeruginosa0 cites
- US12478667utility2025Vaccines for Recurrent Respiratory Papillomatosis and Methods of Using the Same0 cites
- US12285473utility2025Cancer Vaccines Targeting MUC16 and Uses Thereof0 cites
- US12280108utility2025Vaccines Having an Antigen and Interleukin-21 as an Adjuvant0 cites
- US12251561utility2025Minimally Invasive Dermal Electroporation Device0 cites
- US12240872utility2025Filovirus Consensus Antigens, Nucleic Acid Constructs and Vaccines Made Therefrom, and Methods of Using Same0 cites
- US12161706utility2024Cancer Vaccines Targeting BORIS and Uses Thereof0 cites
- US12128229utility2024Oral Mucosal Electroporation Device and Use Thereof0 cites
- US12064473utility2024Cancer Vaccines Targeting Survivin and Uses Thereof0 cites
- US12054537utility2024Optimized Nucleic Acid Antibody Constructs Encoding Anti-respiratory Syncytial Virus (RSV) Antibodies0 cites
- US12049479utility2024Foot and Mouth Disease Virus (FMDV) Consensus Proteins, Coding Sequences Therefor and Vaccines Made Therefrom0 cites
- US11986517utility2024Cancer Vaccines Targeting Mesothelin and Uses Thereof0 cites
- US11980659utility2024Consensus Prostate Antigens, Nucleic Acid Molecule Encoding the Same and Vaccine and Uses Comprising the Same0 cites
- US11981724utility2024DNA Antibody Constructs for Use Against Middle East Respiratory Syndrome Coronavirus0 cites
- US11851477utility2023DNA Monoclonal Antibodies Targeting Influenza Virus0 cites
- US11844830utility2023Vaccines for Human Papilloma Virus and Methods for Using the Same0 cites
- US11845787utility2023DNA Antibody Constructs for Use Against HIV0 cites
- US11801288utility2023Cancer Vaccines and Methods of Treatment Using the Same0 cites
- US11801298utility2023Mers-cov Vaccine0 cites
Page 1 of 2Next →